Bank Hapoalim Bm Eli Lilly & CO Transaction History

Bank Hapoalim Bm

$660 Million
Q3 2024

A detailed history of Bank Hapoalim Bm transactions in Eli Lilly & CO stock. As of the latest transaction made, Bank Hapoalim Bm holds 5,365 shares of LLY stock, worth $4.02 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares

5,365

Previous 5,534 3.05%

Holding current value

$4.02 Million

Previous $5.01 Million 5.13%

% of portfolio

0.72%

Previous 0.71%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$772.14 - $960.02 $130,491 - $162,243	-169 Reduced 3.05%	5,365 $4.75 Million
Q2 2024 Jul 23, 2024	SELL	$724.87 - $909.04 $397,228 - $498,153	-548 Reduced 9.01%	5,534 $5.01 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $515,806 - $690,075	871 Added 16.71%	6,082 $4.73 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $717,409 - $845,731	-1,366 Reduced 20.77%	5,211 $3.04 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $535,550 - $738,337	-1,232 Reduced 15.78%	6,577 $3.53 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $436,671 - $583,880	-1,245 Reduced 13.75%	7,809 $3.66 Million
Q1 2023 Apr 25, 2023	SELL	$310.63 - $364.82 $855,164 - $1 Million	-2,753 Reduced 23.32%	9,054 $3.11 Million
Q4 2022 Jan 26, 2023	SELL	$321.55 - $374.67 $258,847 - $301,609	-805 Reduced 6.38%	11,807 $4.32 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $118,592 - $135,148	-400 Reduced 3.07%	12,612 $4.08 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $1.16 Million - $1.36 Million	4,164 Added 47.06%	13,012 $4.22 Million
Q1 2022 Apr 28, 2022	SELL	$234.69 - $291.66 $281,628 - $349,992	-1,200 Reduced 11.94%	8,848 $2.53 Million
Q4 2021 Feb 04, 2022	SELL	$224.85 - $279.04 $7,195 - $8,929	-32 Reduced 0.32%	10,048 $2.78 Million
Q3 2021 Oct 27, 2021	BUY	$221.6 - $272.71 $23,489 - $28,907	106 Added 1.06%	10,080 $2.33 Million
Q2 2021 Aug 05, 2021	BUY	$180.55 - $233.54 $105,982 - $137,087	587 Added 6.25%	9,974 $2.29 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $255,846 - $331,205	-1,557 Reduced 14.23%	9,387 $1.75 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $2,478 - $3,279	-19 Reduced 0.17%	10,944 $1.85 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $29,244 - $33,826	-200 Reduced 1.79%	10,963 $1.62 Million
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $132,736 - $159,747	-973 Reduced 8.02%	11,163 $1.83 Million
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $7,143 - $8,841	60 Added 0.5%	12,136 $1.68 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $9,943 - $12,315	93 Added 0.78%	12,076 $1.59 Million
Q3 2019 Nov 01, 2019	BUY	$106.79 - $116.16 $224,045 - $243,703	2,098 Added 21.22%	11,983 $1.35 Million
Q1 2019 May 07, 2019	BUY	$111.31 - $131.02 $77,917 - $91,714	700 Added 7.62%	9,885 $1.28 Million
Q2 2018 Jul 24, 2018	SELL	$75.7 - $86.88 $11,355 - $13,032	-150 Reduced 1.61%	9,185 $784,000
Q1 2018 Apr 30, 2018	BUY	$74.21 - $87.6 $148,420 - $175,200	2,000 Added 27.27%	9,335 $722,000
Q3 2017 Nov 07, 2017	BUY	$77.07 - $85.54 $237,375 - $263,463	3,080 Added 72.39%	7,335 $627,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,255	4,255 $350,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Account